Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test

Journal of the National Cancer Institute

Volumn 88, Issue 8, 1996, Pages

  Lancaster, Johnathan M ^a   Cochran, Charles J ^a   Brownlee, Heather A ^a   Evans, A Craig ^b   Berchuck, Andrew ^b   Futreal, P Andrew ^b   Wiseman, Roger W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE ISOLATION; GENE MUTATION; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN DETERMINATION;

BRCA1 PROTEIN; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0029970323     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.8.552     Document Type: Article

References (21)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266: 66-71.
2. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
3. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2 [see comment citation in Medline], Nature 1995;378:789-92.
4. Narod S, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir G, et al. Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium [letter]. Am J Hum Genet 1995;57:957-8.
5. Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992; 2:128-31.
6. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, et al. Consistent loss of the wild type allelc in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995;10: 1673-5.
7. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
8. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 1995;9:439-43.
9. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulke S, Stamp G, et al. A somatic BRCA1 mutation in an ovarian tumour [letter]. Nat Genet 1995;9:343-4.
10. Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 1995;55:2998-3002.
11. Matasushima M, Kobayashi K, Emi M, Saito H, Saito J, Suzumori K, et al. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients. Hum Mol Genet 1995;4:1953-6.
12. Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE. et al. Mutations m the BRCA1 gene in families with earlyonset breast and ovarian cancer. Nat Genet 1994;8:387-91.
13. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994;8:392-8.
14. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8:399-404.
15. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995; 273:535-41.
16. Friend S, Borresen AL, Brody L, Casey G, Devilee P, Gayther S, et al. Breast cancer information on the web [letter]. Nat Genet 1995;11:238-9.
17. Hogervorst FB, Cornelis RS, Bout M, van Vhet M, Oosterwijk JC, Olmer R, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 1995; 10 208-12.
18. Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, et al. Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet 1995;4: 1989-91.
19. van der Luijt R, Khan PM, Vasen H, van Leeuwen C, Tops C, Roest P, et al. Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 1994;20:1-4.
20. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 1995;57:1284-97.
21. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 1995;273:577-85.